SCHEMBL2948596

SCHEMBL2948596

c1ccc2cc(Cc3ncc(-c4ccc5cc(OCc6nnn[nH]6)ccc5c4)o3)ccc2c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.42
KMT2A Q03164 4/20 0.42
GAA P10253 3/20 0.42
ALDH1A1 P00352 2/20 0.42
NPC1 O15118 4/20 0.39
RAB9A P51151 4/20 0.39
MAPT P10636 8/20 0.39
MAPK1 P28482 4/20 0.39
KDM4E B2RXH2 4/20 0.39
LMNA P02545 3/20 0.39
TSHR P16473 2/20 0.39
HSD17B10 Q99714 2/20 0.39
USP2 O75604 1/20 0.39
POLB P06746 1/20 0.39
HPGD P15428 1/20 0.39
TP53 P04637 1/20 0.38
HTT P42858 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
FFAR1 O14842 3/20 0.38
MAOA P21397 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2946398 0.93 FFAR1 (0.39) MEN1KMT2AGAAALDH1A1NPC1
SCHEMBL2946099 0.82 TSHR (0.46) MEN1KMT2AGAAALDH1A1NPC1
SCHEMBL2950785 0.80 CYP1A2 (0.46) MEN1KMT2AALDH1A1NPC1RAB9A
SCHEMBL2941497 0.79 LMNA (0.42) MEN1KMT2AGAAALDH1A1NPC1
SCHEMBL2943816 0.77 PTPN7 (0.56) MEN1KMT2ANPC1RAB9AMAPT
SCHEMBL2943719 0.77 ALOX5 (0.48) FFAR1ALOX5CYP1A2CYP3A4CYP2C19
SCHEMBL2949496 0.74 KDM4E (0.39) MEN1KMT2AGAAALDH1A1NPC1
SCHEMBL9016435 0.73 ALOX5 (0.55) MEN1KMT2AALDH1A1NPC1RAB9A
SCHEMBL2945245 0.73 PTPN1 (0.38)
SCHEMBL26434328 0.73 MIF (0.54) MEN1KMT2AGAAALDH1A1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7754747-B2 Oxazolo-naphthyl acids WYETH LLC (US) 2010-07-13 US claimed
EP-1781645-A1 OXAZOLO-NAPHTHYL ACIDS AS PLASMINOGEN ACTIVATOR INHIBITOR TYPE-1(PAI-1) MODULATORS USEFUL IN THE TREATMENT OF THROMBOSIS AND CARDIOVASCULAR DISEASES Wyeth (US) 2007-05-09 EP claimed
US-20060052348-A1 Oxazolo-naphthyl acids WYETH (US) 2006-03-09 US claimed
WO-2006023865-A1 OXAZOLO-NAPHTHYL ACIDS AS PLAMINOGEN ACTIVATOR INHIBTOR TYPE-1 (PAI-1) MODULATORS USEFUL IN THE TREATMENT OF THROMBOSIS AND CARDIOVASCULAR DISEASES WYETH (US) 2006-03-02 WO claimed
US-7754747-B2 Oxazolo-naphthyl acids WYETH LLC (US) 2010-07-13 US disclosed
EP-1781645-A1 OXAZOLO-NAPHTHYL ACIDS AS PLASMINOGEN ACTIVATOR INHIBITOR TYPE-1(PAI-1) MODULATORS USEFUL IN THE TREATMENT OF THROMBOSIS AND CARDIOVASCULAR DISEASES Wyeth (US) 2007-05-09 EP disclosed
US-20060052348-A1 Oxazolo-naphthyl acids WYETH (US) 2006-03-09 US disclosed
WO-2006023865-A1 OXAZOLO-NAPHTHYL ACIDS AS PLAMINOGEN ACTIVATOR INHIBTOR TYPE-1 (PAI-1) MODULATORS USEFUL IN THE TREATMENT OF THROMBOSIS AND CARDIOVASCULAR DISEASES WYETH (US) 2006-03-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060052348-A1 Oxazolo-naphthyl acids SERPINE1, SERPINB1, SERPINC1 MEN1 2828/4885KMT2A 4416/4885GAA 1353/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.